Phytochemical constituents’ analysis of Rhanterium adpressum Coss & Durieu flowers extracts and their α-amylase and α-glucosidase inhibition properties
{"title":"Phytochemical constituents’ analysis of Rhanterium adpressum Coss & Durieu flowers extracts and their α-amylase and α-glucosidase inhibition properties","authors":"Boussoussa Hadjer, Benabed Khadidja Houda, Khacheba Ihcen, Yousfi Mohamed","doi":"10.2174/1573408019666230418114015","DOIUrl":null,"url":null,"abstract":"\n\nRhanterium adpressum is an endemic and desert plant found in Algerian Sahara, it is used by the local population in cheese production and folk medicine as an antidiuretic and antimicrobial.\n\n\n\nThis study aimed to analyse the phytochemical composition of Rhanterium adpressum extracts by GC-MS and assess their inhibitory potential on α-amylase and α-glucosidase enzymes linked to diabetes.\n\n\n\nTwo solvents were used for extraction: petroleum ether and dichloromethane. The obtained extracts were then analysed by GC-MS and in vitro tested for their antidiabetic activity.\n\n\n\nGC-MS analysis of extracts from R. adpressum flowers revealed various phytocompounds, such as (-)-Spathulenol, alpha.-Amyrin, Lupeol and Cedran-diol in petroleum ether extract; 1H-Cycloprop[e]azulen-7-ol, 5(1H)-Azulenone and alpha-cardinol in dichloromethane extract. Petroleum ether extract exhibited a good in vitro antidiabetic activity in comparison to dichloromethane extract.\n\n\n\nThis research confirms the antidiabetic activity of petroleum ether extract when compared with dichloromethane extract; other studies are needed for purification and in vivo study of bio-compounds from Rhanterium adpressum. This investigation offers scientific data that flowers of Rhanterium adpressum exhibit in vitro anti-diabetic effect.\n","PeriodicalId":35405,"journal":{"name":"Current Enzyme Inhibition","volume":" ","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2023-04-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Current Enzyme Inhibition","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.2174/1573408019666230418114015","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"Pharmacology, Toxicology and Pharmaceutics","Score":null,"Total":0}
引用次数: 0
Abstract
Rhanterium adpressum is an endemic and desert plant found in Algerian Sahara, it is used by the local population in cheese production and folk medicine as an antidiuretic and antimicrobial.
This study aimed to analyse the phytochemical composition of Rhanterium adpressum extracts by GC-MS and assess their inhibitory potential on α-amylase and α-glucosidase enzymes linked to diabetes.
Two solvents were used for extraction: petroleum ether and dichloromethane. The obtained extracts were then analysed by GC-MS and in vitro tested for their antidiabetic activity.
GC-MS analysis of extracts from R. adpressum flowers revealed various phytocompounds, such as (-)-Spathulenol, alpha.-Amyrin, Lupeol and Cedran-diol in petroleum ether extract; 1H-Cycloprop[e]azulen-7-ol, 5(1H)-Azulenone and alpha-cardinol in dichloromethane extract. Petroleum ether extract exhibited a good in vitro antidiabetic activity in comparison to dichloromethane extract.
This research confirms the antidiabetic activity of petroleum ether extract when compared with dichloromethane extract; other studies are needed for purification and in vivo study of bio-compounds from Rhanterium adpressum. This investigation offers scientific data that flowers of Rhanterium adpressum exhibit in vitro anti-diabetic effect.
期刊介绍:
Current Enzyme Inhibition aims to publish all the latest and outstanding developments in enzyme inhibition studies with regards to the mechanisms of inhibitory processes of enzymes, recognition of active sites, and the discovery of agonists and antagonists, leading to the design and development of new drugs of significant therapeutic value. Each issue contains a series of timely, in-depth reviews written by leaders in the field, covering a range of enzymes that can be exploited for drug development. Current Enzyme Inhibition is an essential journal for every pharmaceutical and medicinal chemist who wishes to have up-to-date knowledge about each and every development in the study of enzyme inhibition.